BRPI0520568A2 - uso de esqueleto de parede celular de nocardia rubra na preparação de medicamentos para infecção anti-hpv - Google Patents

uso de esqueleto de parede celular de nocardia rubra na preparação de medicamentos para infecção anti-hpv

Info

Publication number
BRPI0520568A2
BRPI0520568A2 BRPI0520568-9A BRPI0520568A BRPI0520568A2 BR PI0520568 A2 BRPI0520568 A2 BR PI0520568A2 BR PI0520568 A BRPI0520568 A BR PI0520568A BR PI0520568 A2 BRPI0520568 A2 BR PI0520568A2
Authority
BR
Brazil
Prior art keywords
preparation
wall skeleton
cell wall
hpv infection
nocardia rubra
Prior art date
Application number
BRPI0520568-9A
Other languages
English (en)
Inventor
Ce Zhang
Yi Zhang
Xiaoming Hong
Guoying Zhang
Jian Zhao
Original Assignee
Shenyang Sun Bell Com Biopharm
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shenyang Sun Bell Com Biopharm filed Critical Shenyang Sun Bell Com Biopharm
Publication of BRPI0520568A2 publication Critical patent/BRPI0520568A2/pt
Publication of BRPI0520568B1 publication Critical patent/BRPI0520568B1/pt
Publication of BRPI0520568B8 publication Critical patent/BRPI0520568B8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Mycology (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

USO DE ESQUELETO DE PAREDE CELULAR DE NOCARDIA RUBRA NA PREPARAçãO DE MEDICAMENTOS PARA INFECçãO ANTI-HPV. A presente invenção refere-se ao uso de Esqueleto de Parede Celular de Nocardia rubra, especialmente o novo uso do mesmo na preparação de medicamentos anti-HPV.
BRPI0520568A 2005-09-23 2005-11-23 uso de esqueleto de parede celular de nocardia rubra na preparação de medicamentos para infecção anti-hpv BRPI0520568B8 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN200510105533.7 2005-09-23
CN2005101055337A CN1935262B (zh) 2005-09-23 2005-09-23 红色诺卡氏菌细胞壁骨架在制备抗人乳头瘤病毒药物的用途
PCT/CN2005/001977 WO2007033533A1 (en) 2005-09-23 2005-11-23 Use of nocardia rubra cell wall skeleton to produce medicaments for resisting human papilloma virus hpv

Publications (3)

Publication Number Publication Date
BRPI0520568A2 true BRPI0520568A2 (pt) 2009-05-19
BRPI0520568B1 BRPI0520568B1 (pt) 2019-10-08
BRPI0520568B8 BRPI0520568B8 (pt) 2021-05-25

Family

ID=37888528

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0520568A BRPI0520568B8 (pt) 2005-09-23 2005-11-23 uso de esqueleto de parede celular de nocardia rubra na preparação de medicamentos para infecção anti-hpv

Country Status (8)

Country Link
US (1) US8460722B2 (pt)
EP (1) EP1938826B1 (pt)
JP (1) JP4854742B2 (pt)
KR (1) KR20080048542A (pt)
CN (1) CN1935262B (pt)
BR (1) BRPI0520568B8 (pt)
RU (1) RU2394586C2 (pt)
WO (1) WO2007033533A1 (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102526119A (zh) * 2010-12-23 2012-07-04 辽宁纳可佳生物制药有限公司 红色诺卡氏菌细胞壁骨架增强树突状细胞功能的方法
CN108295095A (zh) * 2017-01-11 2018-07-20 福建省山河药业有限公司 红色诺卡氏菌细胞壁骨架在制备治疗痤疮的药物/护肤品中的用途及其药物/护肤品组合物
WO2020147472A1 (zh) * 2019-01-15 2020-07-23 辽宁格瑞仕特生物制药有限公司 赤红球菌产品及其制药用途
CN112040962A (zh) * 2019-03-14 2020-12-04 辽宁格瑞仕特生物制药有限公司 红色诺卡氏菌细胞壁骨架在治疗外阴白色病变中的用途
WO2020216283A1 (zh) 2019-04-24 2020-10-29 辽宁格瑞仕特生物制药有限公司 红色诺卡氏菌细胞壁骨架在治疗热损伤中的用途
KR20220130163A (ko) 2020-01-21 2022-09-26 랴오닝 그레이티스트 바이오-파마슈티컬 컴퍼니 리미티드 재생 의학에서의 노카르디아 루브라 세포벽 골격의 용도
CN115025128A (zh) * 2022-06-24 2022-09-09 辽宁格瑞仕特生物制药有限公司 红色诺卡氏菌细胞壁骨架在治疗宫颈病变中的应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5709860A (en) * 1991-07-25 1998-01-20 Idec Pharmaceuticals Corporation Induction of cytotoxic T-lymphocyte responses
US5393792A (en) * 1991-11-20 1995-02-28 Advance Biofactures Of Curacao, N.V. High dosage topical forms of collagenase
CN1094288A (zh) * 1993-04-23 1994-11-02 福建省微生物研究所 利用红色诺卡氏菌制造细胞壁骨架粉末的方法
JP4859341B2 (ja) 2001-07-19 2012-01-25 昭 林 ヒト免疫療法
CN1291725C (zh) * 2002-03-08 2006-12-27 沈阳胜宝康生物制药有限公司 用于治疗宫颈糜烂的红色诺卡氏菌细胞壁骨架制剂及其制法
WO2004022093A1 (en) 2002-09-06 2004-03-18 University College London Whole bacterial cells as immune modulator
US20060127518A1 (en) * 2003-09-05 2006-06-15 Shenyang Sunbellcom Bio-Pharmaceutical Co. Red nocardia cell wall skeleton preparation process and its therapeutic use on treating cervical erosion
CN1879661B (zh) 2005-06-16 2012-06-20 辽宁纳可佳生物制药有限公司 红色诺卡氏菌细胞壁骨架在制备抗真菌感染的药物中的用途
CN101073583A (zh) 2006-05-19 2007-11-21 沈阳胜宝康生物制药有限公司 红色诺卡氏菌细胞壁骨架在制备药物中的用途

Also Published As

Publication number Publication date
US20090028973A1 (en) 2009-01-29
CN1935262B (zh) 2010-12-29
RU2394586C2 (ru) 2010-07-20
CN1935262A (zh) 2007-03-28
BRPI0520568B1 (pt) 2019-10-08
KR20080048542A (ko) 2008-06-02
EP1938826B1 (en) 2014-11-12
US8460722B2 (en) 2013-06-11
EP1938826A1 (en) 2008-07-02
BRPI0520568B8 (pt) 2021-05-25
RU2008109165A (ru) 2009-10-27
JP2009508883A (ja) 2009-03-05
EP1938826A4 (en) 2011-09-07
WO2007033533A1 (en) 2007-03-29
HK1100533A1 (en) 2007-09-21
JP4854742B2 (ja) 2012-01-18

Similar Documents

Publication Publication Date Title
CL2009002206A1 (es) Compuestos derivados de pirrolo -(2-3-d]-pirimidin-7(6h)-tetrahidrofuran-2-il fosfonamidato, composicion farmaceutica; y su uso en el tratamiento de enfermedades virales.
BRPI0408347B8 (pt) derivados de pirimidina, seu uso, e composição e combinação farmacêuticas
TW200800968A (en) Sulfoximine-substituted pyrimidines, processes for production thereof and use thereof as drugs
MX2010004576A (es) Derivados de pirimidina novedosos.
WO2007098128A3 (en) Phenylephrine-containing liquid formulations
AR058433A1 (es) Derivado de 1,1-dioxido de 1,4-benzotiazepina ,procedimiento para su preparacion ,medicamentos que comprenden este compuesto y su uso
ECSP099044A (es) Compuestos de pirimido fusionados
BRPI0814593A2 (pt) Composto, composição farmacêutica que o contém e uso do composto.
DOP2011000176A (es) Compuestos organicos
ECSP077271A (es) Derivados de pirimidina
BRPI0819936A2 (pt) Preparação farmacêutica, método para produzir células dendríticas, células dendríticas, composição farmacêutica, e, uso de uma célula dendrítica ou uma preparação.
BRPI0717369A2 (pt) Composto, medicamento, composição farmacêutica que o contém e uso do composto.
CL2012003075A1 (es) Composicion farmaceutica en solucion de pazopanib, estable y para uso oftalmico; metodo para la preparacion de dicha solucion.
CR9339A (es) Formas farmaceuticas con propiedades farmacocineticas mejoradas
CL2006001266A1 (es) Formas solidas cristalinas i, ii, iii, iv y v de tigeciclina; procedimiento de preparacion de las formas cristalinas ii, iv y v; composicion farmaceutica que comprende las formas cristalinas; y su uso para tratar infecciones bacterianas.
BRPI0514731A (pt) derivados de pirimidina
EP2816035A3 (en) Compounds as modulators of a mutant CFTR protein and their use for treating diseases associated with CFTR protein malfunction
MX2021015846A (es) Derivados de antraciclina.
CL2007001752A1 (es) Compuesto 4-[5(2-amino-etansulfonil)-isoquinolin-7-il]-fenolo una sal farmaceuticamente aceptable o un hidrato o la sal del mismo;composicion farmaceutica que comprende a dicho compuesto,composicion farmaceutica liofilizada;y uso del compuesto como antineiplasico y/o antiviral.
ATE386534T1 (de) Orale darreichungsform enthaltend probiotische bakterien
BRPI0311189B8 (pt) composições farmacêuticas contendo polimorfo a de flibanserin, bem como seu uso
EA200901393A1 (ru) Фармацевтическая композиция, содержащая гестагены и/или эстрогены и 5 метил-(6s)-тетрагидрофолат
ECSP11010811A (es) Uso de dronedarona para la preparación de un medicamento para la prevención de ictus o ataque isquémico transitorio
WO2008073863A3 (en) Preparation and utility of substituted allylamines
MY134026A (en) ?-carboline derivatives and its pharmaceutical use against depression and anxiety

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B25D Requested change of name of applicant approved

Owner name: SHENYANG SUN BELL COM BIOPHARMACEUTICAL CO., LTD. (CN) ; LIAONING NAKEJIA BIOPHARMACEUTICAL CO., LTD. (CN)

Owner name: SHENYANG SUN BELL COM BIOPHARMACEUTICAL CO., LTD.

B25G Requested change of headquarter approved

Owner name: SHENYANG SUN BELL COM BIOPHARMACEUTICAL CO., LTD.

B25D Requested change of name of applicant approved

Owner name: SHENYANG SUN BELL COM BIOPHARMACEUTICAL CO., LTD.

B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B25K Entry of change of name and/or headquarter and transfer of application, patent and certificate of addition of invention: republication

Owner name: LIAONING GREATEST BIO-PHARMACEUTICAL CO., LTD. (CN

Free format text: RETIFICADO O DESPACHO 25.4 PUBLICADO NA RPI 2508 DE 29/01/2019 SOB O ITEM (71).

B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 08/10/2019, OBSERVADAS AS CONDICOES LEGAIS. (CO) 10 (DEZ) ANOS CONTADOS A PARTIR DE 08/10/2019, OBSERVADAS AS CONDICOES LEGAIS

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 23/11/2005 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF